NDC 68151-4760

Campral

Acamprosate Calcium

Campral is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Acamprosate Calcium.

• Product ID: 68151-4760_e6f9c308-7699-48ef-8c70-c69e938521eb
• NDC: 68151-4760
• Product Type: Human Prescription Drug
• Proprietary Name: Campral
• Generic Name: Acamprosate Calcium
• Dosage Form: Tablet, Delayed Release
• Route of Administration: ORAL
• Marketing Start Date: 2005-01-11
• Marketing Category: NDA / NDA
• Application Number: NDA021431
• Labeler Name: Carilion Materials Management
• Substance Name: ACAMPROSATE CALCIUM
• Active Ingredient Strength: 333 mg/1
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC SPL Data Element Entries

NDC 68151-4760-0 [68151476000]

Campral TABLET, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA021431
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2005-01-11
• Marketing End Date: 2016-07-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
ACAMPROSATE CALCIUM	333 mg/1

OpenFDA Data

• SPL SET ID: fe6f754f-62b4-4c86-805d-221332409516
• Manufacturer:
  • Carilion Materials Management
• UNII:
  • 59375N1D0U
• RxNorm Concept Unique ID - RxCUI:
  • 835726
  • 835728

NDC Crossover Matching brand name "Campral" or generic name "Acamprosate Calcium"

NDC	Brand Name	Generic Name
68151-4760	Campral	acamprosate calcium
0093-5352	Acamprosate Calcium	Acamprosate Calcium
0904-7213	Acamprosate Calcium	Acamprosate Calcium
10135-636	Acamprosate Calcium	Acamprosate Calcium
42291-104	Acamprosate Calcium	Acamprosate Calcium
60687-121	Acamprosate Calcium	Acamprosate Calcium
68382-569	acamprosate calcium	acamprosate calcium
68462-435	Acamprosate Calcium	Acamprosate Calcium
70771-1057	acamprosate calcium	acamprosate calcium